False-Positive Malignant Diagnosis of Nodule Mimicking Lesions by Computer-Aided Thyroid Nodule Analysis in Clinical Ultrasonography Practice by Molnár, Krisztián et al.
diagnostics
Article
False-Positive Malignant Diagnosis of Nodule
Mimicking Lesions by Computer-Aided Thyroid
Nodule Analysis in Clinical Ultrasonography Practice
Krisztián Molnár 1,*, Endre Kálmán 2, Zsófia Hári 1, Omar Giyab 1, Tamás Gáspár 1, Károly Rucz 3 ,
Péter Bogner 1 and Arnold Tóth 1
1 Department of Diagnostic Imaging, University of Pécs Medical School, Ifjúság út 13, 7624 Pécs, Hungary;
bertazsofia013@gmail.com (Z.H.); giyab.omar@pte.hu (O.G.); gaspar.tamas.aok@gmail.com (T.G.);
bogner.peter@pte.hu (P.B.); toth.arnold@pte.hu (A.T.)
2 Department of Pathology, University of Pécs Medical School, Szigeti Út 12, 7643 Pécs, Hungary;
ke6100@gmail.com
3 1st Department of Medicine, Division of Endocrinology, University of Pécs Medical School, Ifjúság út 13,
7624 Pécs, Hungary; klinika@somogy.hu
* Correspondence: molnar.krisztian@pte.hu; Tel.: +36-72-535-801
Received: 13 May 2020; Accepted: 4 June 2020; Published: 6 June 2020


Abstract: This study aims to test computer-aided diagnosis (CAD) for thyroid nodules in clinical
ultrasonography (US) practice with a focus towards identifying thyroid entities associated with CAD
system misdiagnoses. Two-hundred patients referred to thyroid US were prospectively enrolled.
An experienced radiologist evaluated the thyroid nodules and saved axial images for further offline
blinded analysis using a commercially available CAD system. To represent clinical practice, not only
true nodules, but mimicking lesions were also included. Fine needle aspiration biopsy (FNAB) was
performed according to present guidelines. US features and thyroid entities significantly associated with
CAD system misdiagnosis were identified along with the diagnostic accuracy of the radiologist and the
CAD system. Diagnostic specificity regarding the radiologist was significantly (p < 0.05) higher than
when compared with the CAD system (88.1% vs. 40.5%) while no significant difference was found in the
sensitivity (88.6% vs. 80%). Focal inhomogeneities and true nodules in thyroiditis, nodules with coarse
calcification and inspissated colloid cystic nodules were significantly (p < 0.05) associated with CAD
system misdiagnosis as false-positives. The commercially available CAD system is promising when used
to exclude thyroid malignancies, however, it currently may not be able to reduce unnecessary FNABs,
mainly due to the false-positive diagnoses of nodule mimicking lesions.
Keywords: computer-assisted diagnosis; ultrasonography; thyroid nodule; thyroid cancer; diagnostic errors
1. Introduction
Thyroid nodules are present in 4–68% of the global population [1,2]. Thyroid cancer is the most
common malignancy in the endocrine system and is associated with a continuously increasing rate of
incidence [3,4].
Fine needle aspiration biopsy (FNAB) is the primary diagnostic tool used to detect malignancies [5,6].
Ultrasonography (US) plays a major role in indicating FNAB [7,8]. US morphological features indicative of
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malignancy have been extensively studied, and different classification systems have been derived resulting
in a more consistent and accurate differentiation among benign and malignant nodules [9–11].
Admittedly, there is still relatively high inter- and also an intra-observer discrepancy in nodule
evaluation, necessarily resulting in inconsistent and less than desired sensitivity and specificity rates
(52–81% and 54–83%, respectively), with both unnecessary biopsies and missed malignancies [12–14].
The most likely explanation is that nodule assessment relies highly on experience [15–18].
With respect to the expectation of achieving a more reliable, objective, and time-saving approach,
computer-aided diagnosis (CAD) systems for thyroid nodules regarding US have recently been introduced.
These CAD systems have been shown to approximate or even exceed the accuracy among experts in
differentiating thyroid nodules in test image sets [19–29]. Only a handful of studies have tested CAD
systems in clinical practice, still including only selected cases of true nodules [30–33]. To date, most CAD
systems are not generally available and do not enable real-time use. Despite the slightly varied results,
most studies concluded that CAD systems can be best exploited by less experienced users [29,31,32,34,35].
However, the theoretical problem regarding less experienced users applying CAD systems is that
these systems were without exception, tested on representative images of true nodules selected by
experienced specialists, while in clinical practice, the examiner first needs to differentiate true nodules
from mimicking lesions. Moreover, the selection of the most representative plane for analysis itself requires
experience [36,37].
To cite an example, the differentiation of a nodule from a pseudonodule or focal parenchymal
inhomogeneity may be challenging in chronic or subacute thyroiditis [37–41]. This, in turn, is a very
common and important clinical problem, since autoimmune thyroiditis has a very high (up to 20%)
prevalence and is also widely believed to pose a higher risk regarding thyroid malignancies [42,43].
The aim of this study is to test the accuracy of CAD in true clinical thyroid US practice by including
not only true nodules pre-selected by experts as in earlier studies, but mimicking lesions as well. The study
also aims to identify factors and thyroid entities related to systematic CAD errors.
2. Materials and Methods
2.1. Subjects
In this prospective study, 200 consecutive patients were included (167 women, 33 men, average
age = 53.5 years, range = 12–88 years) who were referred to the Department of Radiology of the University
of Pécs, for thyroid US from 2019 February to 2019 June and deemed suitable regarding the study.
The exclusion criteria included negative thyroid US, diagnoses of anatomical variants, and diagnoses of
non-strictly thyroid related pathologies (e.g., parathyroid adenoma, adjacent abscess, adjacent malignancy
of other origin, etc.), since the CAD system used in the present study (see CAD analysis) was developed to
analyze only thyroid lesions. Further exclusion criteria included refusal of FNAB, and non-diagnostic
or inconclusive FNAB (i.e., Thy 1, Thy 3, and Thy 4 according to the Bethesda system for reporting
thyroid cytopathology [44]) without the possibility of re-biopsy or surgery until the preparation of the
manuscript. The reason for excluding these cases was to be able to clearly dichotomize nodules as “benign”
or “requiring surgery/malignant” (see diagnosis definitions) as the study target outcome. Figure 1 depicts
the flow chart of the study population selection.
All patients who underwent FNAB signed the general institutional informed consent regarding
the advantages and risks of FNAB and the possible use of anonymized data for research purposes.
The institutional review board approved the use of anonymized patient data in support of this study and
waived the need for additional informed consent, since the study did not burden patients with other
additional procedures than necessary based on the present clinical recommendations [8,11,45] (Code:
No. 7751-PTE 2019. date: 10 January 2019).
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Figure 1. Flow chart of the study population selection. US = Ultrasonography. FNAB = Fine Needle
Aspiration Biopsy.
2.2. Ultrasonography (US) Examination and Fine Needle Aspiration Biopsy (FNAB), Diagnosis Definitions
All US examinations were performed using a high-end, real-time US system (RS85 A; Samsung Medison
Co. Ltd., Seoul, Korea) and a 3–12 MHz linear probe at a fixed frequency of 10 MHz. Patients were
examined by K.M., a radiologist specializing in head and neck radiology with over ten years of experience
regarding diagnostic and interventional thyroid US.
Standard thyroid US examination was performed with all patients in a supine position and their neck
in hyperextension. Neck lymph node regions, major vessels of the neck, and major salivary glands were
also scanned; however, their findings were not included in the study.
If a thyroid nodule was present, the radiologist evaluated its US morphological features presented in
Table 1. Based on these features, a K-TIRADS score (Korean Thy oid I aging Reporting and Data System)
was as igned (2 = benign, 3 = low suspicion, 4 = i te mediate suspicion, and 5 = high suspicion) [8].
The ason for applying this score sy em w s that sinc it is integrate in the applied CAD (see CAD
analysis), direct compar so s could be performed. A no ule was regarded possibly benign with a
K-TIRADS score of 2 or 3, while poss bly malignant when associated with a score of 4 r 5.
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Table 1. Nodule ultrasonography (US) features assessed by the radiologist and the computer-aided
diagnosis (CAD) system.
US Feature Outcome
Composition
Solid
Partially cystic
Cystic
Echogenicity
Hyper/isoechogenic
Hypoechogenic
Orientation
Parallel
Non-parallel
Margin
Well-defined
Microlobulated
Ill-defined
Spongiform
Appearance
Non-appearance
Shape
Oval-to-round
Irregular
Calcification
No calcification
Macrocalcification
Microcalcification 1
1 with or without macrocalcification.
Additional nodule features were asserted, such as “coarse calcification,” if macrocalcification was
present with the largest diameter exceeding 50% of the nodule’s largest diameter, and “inspissated colloid
cystic nodule” for well-circumscribed, completely avascular, not entirely anechoic nodules with colloid
particles producing a comet tail artifact, which were completely evacuated during aspiration.
If a patient was afflicted with more than one nodule, one showing the highest risk of malignancy,
or in the case of more nodules with the same malignancy risk, the largest nodule was included in the study.
An axial plane B-mode image of all included nodules at their largest diameters was saved for further
CAD analysis.
FNAB indication was based on the present international guidelines [8,11,45] and performed by K.M.
In case of discrepancy, the guideline indicating FNAB was applied. US-guided FNAB was performed
using the parallel needle to probe technique with a 22 G needle using 10 mL syringe and Cameco biopsy
gun; the nodules were panned across to sample their possibly largest portion. The aspirated material
was rapidly expressed onto two glass slides, and two smears were created using the one-step smear
method. One slide was fixed in 95% ethanol for H&E staining, and one was air-dried for May–Grünwald
Giemsa staining. The rest of the obtained material was rinsed in formaldehyde solution for processing
as a cell block. Aspiration was repeated if the material macroscopically appeared to be scanty or bloody.
The cytological specimen was submitted to the cytopathology laboratory along with all relevant clinical and
US information. The cytological analysis was performed by a cytopathologist (E.K.) with over 20 years of
experience in cytopathology. Results were classified according to the Bethesda system regarding reporting
thyroid cytopathology [44].
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Patients with thyroiditis were included in the study. Thyroiditis criteria in the present study included
clinically [46–48] and radiologically [37–41] established thyroiditis, or thyroiditis substantiated by FNAB.
In patients suffering from thyroiditis, the following categories were specified: (a) focal inhomogeneity,
proven not to be a nodule by biopsy or if it was completely unchanged compared with previous examinations
within at least a 2-year timespan and was consistently regarded to be thyroiditis related focal inhomogeneity
by the examiner; (b) pseudonodule substantiated through biopsy or was completely unchanged compared
with previous examinations of at least a 2-year timespan and was consistently regarded as a pseudonodule
by the examiner; (c) true nodule in addition to thyroiditis, which was managed in the same way as nodules
without thyroiditis. In reference to focal in homogeneities and pseudonodules, the examiner assigned a
K-TIRADS score of 1 (no nodule) for further statistical analyses.
An axial plane B-mode image representing these entities at their largest diameters were also saved for
further CAD analysis to assess the accuracy of nodule detection in thyroiditis.
Nodules were regarded malignant or requiring surgery (referred to as “malignant/surgery” in further
texts) if the cytological result was suspicious regarding malignancy (Thy 5), or malignant (Thy 6), and/or
malignancy was evident in the surgical specimen. A benign nodule was diagnosed when any of the
following criteria were met: (i) confirmation of benign status in a surgical specimen; (ii) benign or cystic
cytology of an FNAB (Thy 1c or Thy 2); (iii) benign traits including spongiform or partially cystic nodules
with comet tail artifacts, or pure cysts evident on US; (iv) low suspicion (K-TIRADS 3) nodules under 15 mm
diameter, which were completely unchanged compared with previous examinations of at least a 2-year
timespan, and no clinical poor prognostic factors were present, and therefore, FNAB was not indicated.
2.3. Computer-Aided Diagnosis (CAD) Analysis
S-Detect 2 for thyroid (Samsung Medison Co., Ltd.), which is a commercially available CAD tool
integrated into the real-time US system (Samsung RS85 A) designed to detect and classify thyroid lesions
was used in the study. S-Detect 2 for thyroid is based on convolutional neural network-based deep learning
techniques. S-Detect evaluations were performed offline, so the primary ultrasonography examiner (K.M.)
was blinded to the CAD outcomes. The CAD evaluation was performed by consensus by O.G. and A.T.,
a radiologist with over 5 years of experience in thyroid imaging and a resident with 32 months of supervised
experience in thyroid imaging, respectively, blinded both to the findings of the primary radiological
evaluation and the cytopathological results. The analysis was run on the axial plane images of the nodules,
focal inhomogeneities related to thyroiditis, pseudonodules in thyroiditis, and true nodules besides
thyroiditis stored and marked by the primary examiner (K.M.). The CAD data were obtained by manually
setting a rectangular region of interest around the lesion. The CAD system suggested four different possible
margins for the detected nodule; however, the default one was always used. The software automatically
evaluated the US features of the nodule presented in Table 1. The system is able to incorporate nodule
elasticity and vascularity upon user selection, but these features were omitted in this study. This system
can be set up to provide a simple output as “possibly benign” or “possibly malignant” or to provide a
K-TIRADS score of the lesions. The latter option was used to achieve a more detailed evaluation. A lesion
was regarded possibly CAD benign if the provided K-TIRADS score was 2 or 3, while a nodule with
provided K-TIRADS score of 4 to 5 was regarded as possibly CAD malignant.
2.4. Statistical Analysis
Regarding statistical analysis, data were analyzed using MedCalc Statistical Software, version 18.11.3
(MedCalc Software bvba, Ostend, Belgium, https://www.medcalc.org; 2019) [49].
First, we aimed to identify US features and entities associated with CAD system misdiagnosis;
therefore, we selected cases in which the radiologist’s diagnosis was correct and created two subgroups:
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one in which the CAD was correct and another in which the CAD was incorrect. Between these groups
(CAD correct vs. CAD incorrect), the rates of entities such as focal inhomogeneity related to thyroiditis and
pseudonodule related to thyroiditis (as defined earlier) were statistically compared using the comparison
of the two rates tool [50]. Next, only cases of true nodules were kept in the CAD correct and CAD
incorrect groups (focal inhomogeneity related to thyroiditis and pseudonodule related to thyroiditis
cases were excluded), and the rates of nodule US features assured by the radiologist (coarse calcification,
macrocalcification without coarse calcification, inspissated colloid cystic nodule, true nodule related to
thyroiditis, composition, echogenicity, orientation, margin, spongiform state, shape, and microcalcification)
were statistically compared including the comparison of the two rate tools [50].
Secondly, to assess the effect of these entities and US features related to CAD system misdiagnosis
regarding the overall diagnostic performance, the receiver operating characteristic (ROC) curves with
K-TIRADS scores provided by the examiner or CAD as variables and benign or malignant/surgery diagnosis
as a classification variable in the following groups were compared using the comparison of independent
ROC curves with the methodology by DeLong et al. [51–55]: (a) total cohort, human rating, (b) total cohort,
CAD rating, (c) a subgroup derived from the total cohort by excluding all cases in which the entities or US
features identified to be significantly associated with CAD system misdiagnosis were present (=“screened
subgroup”), CAD rating, and (d) the same screened subgroup, human rating.
Third, among these four groups, the sensitivity, specificity, and accuracy were compared using
the McNemar test in reference to dependent sample comparisons and Pearson’s Chi-squared test for
independent samples.
All these steps regarding statistical analysis were additionally run in the group including only those
patients who had an FNAB (FNAB-only group).
As an ancillary step, the number of cases in which the radiologist’s diagnosis was incorrect but the
CAD system diagnosis was correct was calculated.
Tests resulting with a p-value of <0.05 were considered statistically significant.
3. Results
Table 2 presents the occurrence of cases and diagnoses.
3.1. US Features or Entities Associated with CAD System Misdiagnosis Including Mimicking Lesions
In 176 out of the 200 cases, the radiologist made a correct diagnosis. Out of these 176 cases, the CAD
was correct in 83 and incorrect in 93 cases. Focal inhomogeneities related to thyroiditis were in a significantly
higher rate present in the CAD incorrect group; the CAD system identified these lesions as nodules and
assigned them a median K-TIRADS score of 5 (see Table 3). Figure 2 shows representative cases of focal
inhomogeneity related to CAD system misdiagnosis.
3.2. US Features or Entities Associated with CAD System Misdiagnosis Excluding Mimicking Lesions
CAD was correct in 78 case and incorrect in 64 cases, regarding true nodules within the group in
which a correct diagnosis was made by the radiologist (n = 142). True nodules related to thyroiditis, coarse
macrocalcifications, and inspissated colloid cystic nodules were in a significantly higher rate present in the
CAD incorrect group vs. the CAD correct group, with median CAD system K-TIRADS scores of 4, 5, and 4,
respectively, while only one truly malignant case was present within these groups (Table 3). Figure 3 shows
representative cases of these US features related to CAD system misdiagnosis. Non-parallel orientation,
ill-defined margin, and irregular shape were in a significantly higher rate present in the CAD correct group
and they were all malignant/surgery cases (Table 3). A representative example is shown in Figure 4.
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Table 2. Occurrence of thyroid cases and diagnoses.
Case/Diagnosis/Feature Number
Malignant-surgery diagnosis/all 15 a/200
Radiologist possible malignancies (/correct) 35 (/13)
CAD system possible malignancies (/correct) 122 (/12)
Radiologist missed malignancies 2
CAD system missed malignancies 3
Thyroiditis b cases
all 43
with true nodules 9
with pseudonodules 8
with focal inhomogeneities 26
Nodule features of interest
coarse macrocalcification 12
non-coarse macrocalcification 10
inspissated colloid 5
FNAB
all 121
in focal inhomogeneity 14
in nodule with coarse
macrocalcification 7
in nodule with non-coarse
macrocalcification 4
in inspissated colloid cystic nodule 4
in true nodule related to thyroiditis 5
Radiologist K-TIRADS scores 1/2/3/4/5 34/31/100/17/18
CAD system K-TIRADS scores 1/2/3/4/5 0/9/69/53/69
Lesion size (largest diameter, mm)
min 8
max 42
average 14
a 11 histologically malignant cases (10 papillary cancer, 1 follicular cancer) and 4 cases of a result of Bethesda system
Thy 5; b 38 Hashimoto thyroiditis, 2 subacute thyroiditis, and 4 Graves’ disease cases.
Results of the same tests run in the FNAB only group (n = 121) are presented in Supplementary
Materials Table S1.
Out of the 24 cases where the radiologist’s diagnosis was incorrect, the CAD was correct in four cases.
In all of them the radiologist gave a TIRADS score of 4, while the CAD gave a TIRADS score of 3, and these
cases were proven to be benign by cytology.
3.3. Comparison of Human and CAD System Diagnostic Performance in the Total and in the Screened Subgroup
Regarding all cases, human specificity (88.1%) and accuracy (88%) in detecting malignancies were
significantly higher than when compared with those of the CAD (40.5% and 43.5%, respectively). There was
no significant difference in sensitivity (human sensitivity = 88.6%, CAD sensitivity = 80%). ROC curve
comparison showed a significant difference in areas under the curves (AUROCs), which were 0.937 for the
human detections and 0.656 for the CAD detections.
The exclusion of cases of US features and entities identified to be related to CAD system misdiagnosis
(cases of focal inhomogeneity in thyroiditis, true nodule in thyroiditis, coarse macrocalcification,
and inspissated colloid cystic nodule) from the study population resulted in a “screened” subgroup
including 148 cases. In this group, a significant improvement in the specificity of CAD compared to its
specificity achieved in all cases could be detected; specificity in the screened subgroup increased to 55.9%.
However, no significant change was observed regarding sensitivity, accuracy, and AUROC.
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Table 3. Relationship between thyroid entities, US nodule characteristics, and CAD accuracy.
Thyroid Entities *
Rate
p2
CAD TIRADS 3 Rates Malignancies/Diagnosed 4
CAD 1 Correct Group CAD Incorrect Group 1 2 3 4 5
Mimicking lesions
Focal
inhomogeneity
(thyroiditis)
0 26 <0.0001 0 0 0 2 24 0/0
Pseudonodule
in thyroiditis 5 3 0.48 0 0 5 0 3 0/0
True nodules
True nodule
in thyroiditis 1 8 0.019 0 0 0 8 1 1/1
Macrocalcification
non-coarse 4 5 0.527 0 0 3 3 3 0/0
Coarse
macrocalcification 0 12 0.0001 0 0 0 1 11 0/0
Inspissated
colloid
cystic nodule
0 5 0.014 0 0 0 3 2 0/0
US features *
Composition
Solid 30 30 0.442 0 0 18 16 26 12/12
Partially cystic 34 29 0.878 0 2 33 22 6 1/0
Cystic 14 5 0.1 0 7 7 4 1 0/0
Echogenicity
Hyper/isoechoic 58 54 0.5 0 6 53 37 16 1/0
Hypoechoic 20 10 0.2 0 3 5 5 17 12/12
Orientation
Parallel 68 63 0.487 0 9 57 41 24 4/3
Non-parallel 10 1 0.017 0 0 1 1 9 10/10
Margin
Well-defined 65 58 0.642 0 9 56 37 21 2/1
Microlobulated 5 5 0.754 0 0 2 4 4 3/3
Ill-defined 8 1 0.04 0 0 0 1 8 8/8
Spongiform
Appearance 11 8 0.8 0 2 9 7 1 0/0
Non-appearance 67 56 0.919 0 7 49 35 32 13/12
Shape
Ovoid to
round 71 64 0.585 0 9 58 40 28 6/5
Irregular 7 0 0.017 0 0 0 2 5 7/7
Microcalcification 5 1 0.162 0 0 1 1 4 6/5
1 Computer aided diagnosis; 2 p value for comparison of rates; 3 K-TIRADS score; 4 malignant cases and cases requiring
surgery/correctly diagnosed malignancies and cases requiring surgery by CAD per subgroups; lines with bold letters
indicate entities and US nodule characteristics significantly associated with CAD misdiagnosis; lines with italic letters
indicate US nodule characteristics significantly associated with correct CAD system diagnosis; * based on the radiologist’s
evaluation, including only those cases (n = 176), in which the radiologist’s diagnosis was proven correct by either
cytology (if performed based on present recommendations) or clinical data (see methods diagnosis definitions). For US
feature analyses, only cases of true nodules were included (n = 142).
The comparison of human and CAD diagnostic performance in the screened subgroup showed similar
results as in the group of all patients since the difference in specificity, accuracy, and AUROC remained
significant, while sensitivity was not significantly different.
Neither diagnostic parameters showed a significant difference among the total and the screened
subgroup human detections.
Table 4 shows details of diagnostic parameters of human and CAD detections in the total population
and in the screened subgroup, including their comparisons.
Figure 5 shows ROC curves yielded by human and CAD in the total population and in the
screened subgroup.
Results of the same tests conducted in the FNAB-only group (n = 121) are presented in Supplementary
Materials Table S2.
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Figure 3. Representative images of CAD system false-positive misdiagnoses of nodules ((a,b) nodule besides
thyroiditis, (c,d) nodule with coarse calcification, (e–g) inspissated colloid cystic nodule). (a) (B-mode thyroid
US, axial) A 64-year-old female patient with clinically known Hashimoto thyroiditis. In addition to focal
inhomogen ities due to thyroiditis, a true nodule can be depicted in the right lobe, regarded benign
and K-TIRADS 3 by the radiologist. FNAB was performe and yielded a benign result (Thy 2).
(b) (CAD output image) The CAD system provided a high suspicion for malignancy (K-TIRADS 5)
diagnosis. (c) (B-mode thyroid US, axial) A 63-year-old male patient with confluent well circumscribed
isoechoic, partially cystic nodules in the left thyroid lobe with a coarse macrocalcification, scored K-TIRADS
3 nodule by the radiologist. FNAB provided benign diagnosis (Thy 2). (d) (CAD output image) The
CAD system yielded a result of high suspicion for malignancy (K-TIRADS 5). (e) (B-mode thyroid
US, axial) A 71-year-old male patient presenting with several clinically and radiologically pathological
lymph nodes in right cervical lymph node regions and a nodule in the right thyroid lobe, which was
well circumscribed, completely avascular, contained echogenic foci with comet tail artefacts, and was
hypoechogenic. The radiologist diagnosed an inspissated colloid cystic nodule (K-TIRADS 2), yet performed
FNAB due to the presence of pathological lymph nodes. (f) (B-mode thyroid US, axial, insert) During FNAB,
the fluid content of the nodule was completely removed. The pathological lymph nodes were proved to be
squamous cell carcinoma metastases, while the thyroid nodule was diagnosed benign (Thy 1c) by cytology.
(g) (CAD output image) The CAD system rated the nodule to be possibly malignant, with an intermediate
suspicion for malignancy (K-TIRADS 4).
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Figure 4. Representative image of a malignant nodule (a), correctly diagnosed by the CAD system (b).
(a) (B-mode thyroid US, axial) This 26-year-old female patient had a nodule in the right thyroid lobe
characterized as solid, hypoechoic, non-parallel, ill-defined, and irregularly shaped with microcalcifications
by the radiologist. (b) (CAD output image) Although the CAD system did not agree in all US classification
features, the outcome of high suspicion regarding malignancy (K-TIRADS 5) concurred with the radiologist’s
diagnosis. Cytology and histology confirmed the presence of papillary thyroid cancer.
Table 4. Diagnostic parameters of human and CAD 1 detections in the total and screened 2 subgroup for
malignancies 3.
Diagnostic
Parameter
Human, All CAD, All CAD,
Screened
Human,
Screened
p Values of Comparisons 4
Human vs.
CAD All
Human vs.
CAD Screened
CAD all vs.
Screened
Human All vs.
Screened
Sensitivity 88.67% 80% 78.57% 85.71% 1 1 0.92 0.94
Specificity 88.11% 40.54% 55.97% 84.33% <0.0001 <0.0001 0.007 0.33
Accuracy 88% 43.5% 58.1% 84.46% <0.0001 <0.0001 0.12 0.8
PPV 5 37.14% 9.84% 15.71% 36.36%
NPV 6 98.79% 96.15% 96.15% 98.26%
ROC
AUC 7 0.937 0.656 0.76 0.922 0.0002 0.049 0.289 0.782
1 Computer aided diagnosis; 2 subgroup in which cases of thyroid entities and US characteristics identified to be
associated with CAD misdiagnosis are excluded (see Table 1); 3 malignant cases or cases requiring surgery; 4 McNemar
test for paired comparisons, Pearson’s chi squared test for unpaired comparisons; 5 positive predictive value; 6 negative
predictive value; 7 receiver operator characteristic area under the curve.Diagnostics 2020, 10, x FOR PEER REVIEW 12 of 17 
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4. Discussion
To the best of our knowledge, no previous study has considered the importance of nodule mimicking
lesions when applying CAD systems for thyroid. CAD systems were trained on true nodules and often
shown to even outperform humans. In our opinion, such results may be very misleading regarding the
actual feasibility of CAD systems, since they do not represent clinical practice, in which thyroid lesion
differentiation (nodule vs. mimicking lesion) is of utmost importance. Such differentiation might be
challenging, especially for less experienced users—the ones most probably willing to apply CAD. To test
the significance of this problem, the present study focused not only on true nodules but mimicking lesions
as well.
The overall diagnostic performance (AUROC and accuracy) regarding the experienced radiologist
was comparable to previous studies [30,31,33], and was significantly higher when compared with the
CAD system. The most substantial difference was found in specificity and positive predictive value,
which were, respectively, roughly two and four times higher for the radiologist’s detections. However,
there was no significant difference in sensitivities, and negative predictive values were also very close.
In the study by Kim et al. [32], who applied the same commercial CAD system S-Detect 2, CAD sensitivity
(81.4%) and negative predictive value (84.9%) vs. radiologist (sensitivity = 84.9%, negative predictive
value = 90.7%) were also similar, and CAD specificity (68.2%) was also significantly lower than that of the
radiologist (96.2%). However, in our study, CAD specificity was even lower (40.5%). This is most likely
due to the fact that in our study, not only cases of true nodules pre-selected by an expert were included,
but also cases posing differential diagnostic problem for nodules such as focal inhomogeneities as well.
Another important difference regarding the populations of the two studies is that Kim et al. included
patients who were prior to scheduled surgery, and almost half of the analyzed nodules were malignant,
while in the present study most patients underwent US for the first time or returned for a check-up of a
benign thyroid entity, which resulted in a lower proportion of malignancies.
Thyroiditis related focal inhomogeneity appeared to be a differential diagnostic entity related to
systematic CAD system misdiagnosis, i.e., false-positive detection, since the CAD system appreciated
them as a nodule and almost always assigned them a K-TIRADS score of 5 due to “ill-defined borders”
and “hypoechogenicity”. In clinical practice, especially with less experienced users, such false-positive
misdiagnoses may lead to high rates of unnecessary FNAB indications, keeping the high incidence of
chronic thyroiditis in mind [42,43].
When considering true nodules, CAD system misdiagnosis was most strikingly related to nodules
associated with coarse macrocalcifications. All of them were diagnosed false-positively as possibly
malignant and were mostly assigned a K-TIRADS score of 5. We assume this is due to the acoustic
shadow being assessed as solid hypoechogenicity with ill-defined borders. Inspissated colloid cystic
nodules, proved by the aspiration of their fluid content and cytology, were again diagnosed as possibly
malignant and were assigned a K-TIRADS score of 4 or 5 nodules by the CAD, mostly diagnosed with
solid hypoechoic composition and microcalcification instead of colloid particles. The likelihood of CAD
being inaccurate while evaluating microcalcification was also presented by Kim et al. [32].
US features such as ill-defined contour, non-parallel orientation, and irregular shape were, in turn,
significantly associated with correct diagnosis by the CAD system. This is aligned with the finding
regarding high CAD sensitivity, since all of these features are known to be associated with the risk of
malignancy [8] and seem to be accurately picked up by the CAD.
In contrast with our results, several studies of non-commercial, yet offline applicable
algorithms presented artificial diagnostic performance being as good or even better than radiologists’
performance [19,20,29,34,56]. These studies included a very high (approximately 30–50%) rate of
malignancies compared to “real life” thyroid malignancy incidence and malignant nodule rate [3,4,6].
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Furthermore, in all these studies, the validation sets included only true nodules pre-selected by experts.
Such nodule pre-selection and the acquisition of the most representative slice performed by humans is
obviously a diagnostic procedure possibly significant in helping CAD systems to achieve their promising
diagnostic performance results. This is underscored by our result in which the exclusion of cases posing
thyroid nodule differential diagnosis (see results related to the exclusion of the “screened subgroup”)
significantly improves CAD outcomes. Moreover, Jeong et al. [36] showed how CAD outcomes are
significantly operator dependent, even if operators run the analysis on exactly the same images of
pre-selected nodules; however, they may differently position the nodule region of interest and select
nodule contours.
In this study, the radiologist had the possibility to consider clinical data and scan the entire lesions
for lesion differentiation and scoring. This might have constituted an advantage regarding diagnostic
performance versus the CAD system, which could not rely on clinical data, and analyzed the lesions based
on single slice images. However, the aim of this study was to make a comparison under true clinical
circumstances and to find CAD limitations. To overcome such possible CAD shortcomings, the authors
speculate that future CAD systems should have the option of including clinical data and the option of
analyzing 3D inputs. Some attempts towards 3D nodule analysis have been already done [57,58].
It is important to note that there are certain differences among the different TIRADS systems (such as
ACR and EU TIRADS) compared to the presently applied K-TIRADS; for a comparison of these systems,
see the review by Chiara et al. [59].
This study has certain limitations. First, not all patients underwent FNAB. In these cases, however,
the chance of malignancy was firmly ruled out according to strict criteria. The authors alleged including
these cases to be relevant in effectively evaluating CAD performance in routine clinical practice and
not only on human-selected nodules requiring FNAB. Still, the inclusion of non-FNAB cases carries the
possibility of bias since the examination was performed by a single expert. Therefore, we ran all statistics
in the FNAB-only group as well (see Supplementary Materials), which did not affect the main messages
of the study. Second, in this study not only histologically confirmed malignancies or cytological Thy 6
cases were included as positives (malignant/surgery), but cytological Thy 5 cases as well, since we believe
that the aim of thyroid US is primarily to detect nodules that require surgery and not substituting FNAB
by attempting to provide final diagnosis. The number of Thy 5 cases without final histological diagnosis
was, however, low (4 cases out of 200, 2%), and in all except of one of these cases, the CAD outcome
(possibly malignant) was correct and was in agreement with the human outcome; therefore, including
these cases did not affect the main findings of the present study related to false positive CAD results. Third,
no correction for multiple comparisons was performed when identifying US entities and features possibly
related to CAD system misdiagnosis. Nevertheless, the fact that all cases in these groups (except one truly
malignant nodule related to thyroiditis) were false positive, and the exclusion of these cases significantly
affected diagnostic specificity, is reassuring regarding the validity of this finding. Fourth, only a single
CAD system was tested in this study; however, the results regarding misdiagnosis of nodule mimicking
lesions most probably apply to all other thyroid US CAD systems, since to date none of them were reported
to consider mimicking lesions. Fifth, it was not possible to analyze the causes of false-negative CAD
detections because of the very low number of these cases (n = 3).
5. Conclusions
In a routine clinical thyroid US population, the commercially available CAD seems to be applicable
for screening patients with the aim of excluding thyroid malignancies. However, certain nodule types,
and especially mimicking lesions, resulted in systematic false-positive malignant diagnoses for this CAD
system. Therefore, this system (and probably any system trained on true nodules only) may not be entirely
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effective in reducing unnecessary FNABs, especially when used by inexperienced users for whom the
diagnosis of the above-mentioned entities may also prove daunting.
Future CAD systems regarding thyroid may be most useful in clinical practice if mimicking lesions
were added to their training sets.
Supplementary Materials: The following are available online at http://www.mdpi.com/2075-4418/10/6/378/s1, Table S1:
Relationship between thyroid entities, US nodule characteristics, and CAD accuracy in the FNAB-only group. Table S2:
Diagnostic parameters of human and CAD detections in the total and screened subgroup for malignancies in the
FNAB-only group.
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